Description

This issue of Vital Signs, released on March 31, 2008, provides an strategic overview of selected lucrative market areas in the pharmaceutical industry. Additionally, a company spotlight is provided for Arena Pharmaceuticals, a clinical stage biopharmaceutical company focusing on developing innovative oral drugs for patients with serious diseases and disorders. Reimbursement and regulatory news from the FDA is also provided for the week of March 17 - March 21, 2008.